Literature DB >> 26619494

Completion of Latent Tuberculosis Therapy in Children: Impact of Country of Origin and Neighborhood Clinics.

Kevin B Spicer1, Lori Perkins2, Ben DeJesus3, Shu-Hua Wang4, Dwight A Powell1.   

Abstract

BACKGROUND: Successful treatment of latent tuberculosis infection (LTBI) is an important objective in the United States' strategy for tuberculosis (TB) control. We review the impact of demographic variables and community treatment upon completion of medical therapy of LTBI in a large pediatric cohort.
METHODS: We performed a retrospective analysis of prospectively collected data from children referred for evaluation and treatment of LTBI. Children were followed in the main hospital TB clinic or in 1 of 2 hospital-run neighborhood clinics. Those completing and not completing medical treatment were compared based on demographic and history variables, clinic location, and distance to clinic. Propensity score techniques were used to match children treated at the main hospital and neighborhood clinics on collected demographic and history variables.
RESULTS: Of 1516 children evaluated, 1184 (78.1%) initiated medical therapy and returned for at least 1 visit. Of these, treatment was completed by 89.2% (166 of 186) of children in the neighborhood clinics versus 83.2% (830 of 998) of children in the main hospital TB clinic (P < .037). Neighborhood and main hospital clinic children did not differ in rates of completion when propensity score-matched groups were compared. Country of origin was the most important factor in determining both initiation and completion of therapy.
CONCLUSIONS: Obstacles remain for successful initiation and treatment of children from identified geographic regions. Most of the dropout occurs early in treatment, and use of neighborhood clinics does not provide an obvious advantage when similar patient groups are compared. Emphasis upon initial education and early non-clinic follow-up may be useful in enhancing therapy completion.
© The Author 2013. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2013        PMID: 26619494     DOI: 10.1093/jpids/pit015

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  2 in total

1.  Latent tuberculosis treatment completion rates from prescription drug administrative data.

Authors:  Pierre J Plourde; Christopher A Basham; Shelley Derksen; Jennifer Schultz; Scott McCulloch; Linda Larcombe; Kathi Avery Kinew; Lisa M Lix
Journal:  Can J Public Health       Date:  2019-07-11

Review 2.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.